Motif ID: Ybx1_Nfya_Nfyb_Nfyc_Cebpz
Z-value: 5.954





Transcription factors associated with Ybx1_Nfya_Nfyb_Nfyc_Cebpz:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Cebpz | ENSMUSG00000024081.8 | Cebpz |
Nfya | ENSMUSG00000023994.7 | Nfya |
Nfyb | ENSMUSG00000020248.12 | Nfyb |
Nfyc | ENSMUSG00000032897.11 | Nfyc |
Ybx1 | ENSMUSG00000028639.8 | Ybx1 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Ybx1 | mm10_v2_chr4_-_119294520_119294604 | 0.75 | 1.4e-08 | Click! |
Nfyb | mm10_v2_chr10_-_82764088_82764144 | -0.75 | 1.5e-08 | Click! |
Cebpz | mm10_v2_chr17_-_78937031_78937074 | -0.40 | 9.5e-03 | Click! |
Nfyc | mm10_v2_chr4_-_120825665_120825707 | -0.27 | 8.3e-02 | Click! |
Nfya | mm10_v2_chr17_-_48409729_48409906 | -0.26 | 1.1e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.7 | 38.0 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
12.3 | 73.9 | GO:0072049 | comma-shaped body morphogenesis(GO:0072049) |
10.3 | 82.4 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
8.6 | 17.2 | GO:0072190 | ureter urothelium development(GO:0072190) ureter morphogenesis(GO:0072197) |
7.7 | 23.2 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
7.3 | 21.9 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
7.3 | 29.1 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
7.2 | 21.7 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) DNA replication preinitiation complex assembly(GO:0071163) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
7.0 | 21.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
6.9 | 48.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
6.9 | 123.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
6.8 | 20.5 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
6.8 | 20.5 | GO:0061075 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
6.8 | 20.4 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
6.7 | 40.4 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
6.4 | 12.8 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
6.4 | 19.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
5.5 | 27.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
5.5 | 16.4 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
5.2 | 15.7 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
5.2 | 31.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
5.0 | 14.9 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
4.8 | 14.4 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
4.8 | 14.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
4.8 | 14.4 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
4.8 | 148.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
4.7 | 14.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
4.7 | 60.7 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
4.6 | 32.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
4.5 | 9.0 | GO:0072180 | mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
4.4 | 13.3 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
4.4 | 13.3 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) cardiac cell fate determination(GO:0060913) |
4.2 | 4.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
4.2 | 71.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
3.9 | 11.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
3.8 | 3.8 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
3.6 | 21.7 | GO:0000279 | M phase(GO:0000279) |
3.6 | 57.5 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
3.6 | 17.9 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
3.5 | 10.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
3.5 | 35.2 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
3.5 | 10.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
3.5 | 10.5 | GO:0021759 | globus pallidus development(GO:0021759) |
3.4 | 17.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
3.3 | 10.0 | GO:0045819 | plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
3.3 | 23.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
3.3 | 9.8 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
3.2 | 12.8 | GO:0006272 | leading strand elongation(GO:0006272) |
3.2 | 12.7 | GO:1903463 | regulation of mitotic cell cycle DNA replication(GO:1903463) |
3.2 | 9.5 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
3.1 | 6.1 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
3.0 | 9.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) calcium-independent cell-matrix adhesion(GO:0007161) transforming growth factor-beta secretion(GO:0038044) |
3.0 | 6.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
3.0 | 8.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
2.9 | 8.7 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
2.9 | 8.7 | GO:0003195 | tricuspid valve formation(GO:0003195) |
2.9 | 5.7 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
2.8 | 11.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
2.8 | 33.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
2.8 | 35.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
2.7 | 5.4 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
2.7 | 29.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
2.6 | 7.9 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
2.6 | 13.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
2.6 | 15.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
2.6 | 7.8 | GO:0030862 | neuroblast division in subventricular zone(GO:0021849) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
2.6 | 7.8 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
2.6 | 30.9 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
2.5 | 22.9 | GO:0033504 | floor plate development(GO:0033504) |
2.5 | 15.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
2.5 | 7.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
2.5 | 12.6 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
2.5 | 17.6 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
2.5 | 22.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
2.5 | 9.9 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
2.5 | 17.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
2.4 | 2.4 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
2.4 | 9.7 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
2.4 | 2.4 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
2.4 | 7.1 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
2.3 | 7.0 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
2.3 | 6.9 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
2.3 | 13.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
2.3 | 4.6 | GO:0030222 | eosinophil differentiation(GO:0030222) |
2.3 | 6.9 | GO:0036292 | DNA rewinding(GO:0036292) |
2.3 | 9.1 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
2.2 | 31.5 | GO:0043486 | histone exchange(GO:0043486) |
2.2 | 4.5 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
2.2 | 2.2 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
2.2 | 17.3 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
2.2 | 6.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
2.1 | 6.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
2.1 | 54.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
2.1 | 49.7 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
2.1 | 8.2 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
2.1 | 14.4 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
2.0 | 10.2 | GO:0006868 | glutamine transport(GO:0006868) |
2.0 | 12.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
2.0 | 6.1 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
2.0 | 6.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
2.0 | 23.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
2.0 | 39.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
1.9 | 23.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
1.9 | 9.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.9 | 9.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.8 | 9.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.8 | 34.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
1.8 | 1.8 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.8 | 9.1 | GO:0090669 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) telomerase RNA stabilization(GO:0090669) |
1.8 | 12.7 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
1.8 | 5.4 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.8 | 3.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
1.8 | 10.5 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
1.7 | 8.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.7 | 13.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.7 | 6.7 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
1.7 | 5.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.6 | 4.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.6 | 9.7 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
1.6 | 6.4 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.6 | 15.9 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
1.6 | 14.0 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
1.5 | 16.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.5 | 4.6 | GO:0060290 | transdifferentiation(GO:0060290) |
1.5 | 4.6 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
1.5 | 33.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
1.5 | 6.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.5 | 6.0 | GO:0034214 | protein hexamerization(GO:0034214) |
1.5 | 10.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.5 | 1.5 | GO:0051026 | chiasma assembly(GO:0051026) |
1.5 | 5.8 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
1.5 | 2.9 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
1.4 | 5.8 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.4 | 5.7 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
1.4 | 4.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.4 | 11.3 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.4 | 1.4 | GO:0051299 | centrosome separation(GO:0051299) |
1.4 | 4.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
1.4 | 129.5 | GO:0006342 | chromatin silencing(GO:0006342) |
1.4 | 16.3 | GO:0030238 | male sex determination(GO:0030238) |
1.4 | 4.1 | GO:0042637 | catagen(GO:0042637) |
1.3 | 4.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
1.3 | 17.3 | GO:0001675 | acrosome assembly(GO:0001675) |
1.3 | 15.9 | GO:0031639 | plasminogen activation(GO:0031639) |
1.3 | 2.6 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
1.3 | 6.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.3 | 60.5 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
1.3 | 5.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.3 | 3.9 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.3 | 2.6 | GO:0002481 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
1.3 | 3.9 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
1.3 | 16.6 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
1.3 | 3.8 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
1.3 | 8.9 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.3 | 6.3 | GO:0006544 | glycine metabolic process(GO:0006544) |
1.2 | 9.9 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
1.2 | 7.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.2 | 13.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.2 | 1.2 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
1.2 | 5.9 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
1.2 | 8.3 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
1.2 | 10.6 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
1.2 | 6.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.2 | 9.2 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.2 | 1.2 | GO:0032796 | uropod organization(GO:0032796) |
1.1 | 19.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.1 | 6.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.1 | 7.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
1.1 | 6.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.1 | 21.1 | GO:0007099 | centriole replication(GO:0007099) |
1.1 | 1.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
1.1 | 25.3 | GO:0006298 | mismatch repair(GO:0006298) |
1.1 | 7.7 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
1.1 | 4.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.1 | 2.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
1.1 | 7.6 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
1.1 | 3.2 | GO:2000850 | protein-chromophore linkage(GO:0018298) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.1 | 3.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.1 | 4.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.1 | 2.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.0 | 4.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.0 | 14.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.0 | 5.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.0 | 2.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.0 | 16.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
1.0 | 10.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.0 | 3.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
1.0 | 5.9 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
1.0 | 10.9 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
1.0 | 3.9 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.0 | 2.9 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
1.0 | 1.9 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.9 | 3.8 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.9 | 4.7 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.9 | 2.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.9 | 8.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.9 | 2.8 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.9 | 3.7 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.9 | 2.8 | GO:0072172 | ureteric bud formation(GO:0060676) mesonephric tubule formation(GO:0072172) |
0.9 | 5.5 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.9 | 1.8 | GO:0019230 | proprioception(GO:0019230) |
0.9 | 3.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.9 | 1.8 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.9 | 2.7 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.9 | 5.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.9 | 10.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.9 | 14.6 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.9 | 46.3 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.9 | 6.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.9 | 5.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.9 | 3.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.8 | 5.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.8 | 0.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.8 | 2.5 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
0.8 | 12.5 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.8 | 1.7 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.8 | 8.3 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.8 | 2.5 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.8 | 18.8 | GO:0001709 | cell fate determination(GO:0001709) |
0.8 | 0.8 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.8 | 3.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.8 | 4.8 | GO:0007530 | sex determination(GO:0007530) |
0.8 | 1.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.8 | 4.8 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.8 | 6.4 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.8 | 2.4 | GO:0030070 | insulin processing(GO:0030070) |
0.8 | 7.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.8 | 1.6 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.8 | 3.9 | GO:1990839 | response to endothelin(GO:1990839) |
0.8 | 11.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.8 | 2.3 | GO:0060667 | orbitofrontal cortex development(GO:0021769) fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) mammary gland specification(GO:0060594) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
0.8 | 4.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.8 | 10.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.8 | 3.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.8 | 2.3 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.8 | 3.0 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.8 | 13.5 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.8 | 1.5 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
0.7 | 2.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.7 | 2.2 | GO:0072174 | metanephric tubule formation(GO:0072174) metanephric nephron tubule formation(GO:0072289) |
0.7 | 3.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.7 | 2.2 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.7 | 2.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.7 | 2.1 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.7 | 18.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.7 | 2.8 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.7 | 2.8 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.7 | 2.8 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.7 | 1.4 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.7 | 4.2 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.7 | 6.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.7 | 3.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.7 | 2.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.7 | 5.5 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.7 | 9.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.7 | 6.8 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.7 | 2.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.7 | 10.8 | GO:0007398 | ectoderm development(GO:0007398) |
0.7 | 14.7 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.7 | 2.7 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.7 | 2.6 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.6 | 5.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.6 | 1.9 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.6 | 14.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.6 | 3.8 | GO:0044241 | lipid digestion(GO:0044241) |
0.6 | 6.8 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.6 | 2.5 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.6 | 2.5 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.6 | 1.8 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.6 | 2.5 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 3.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.6 | 6.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.6 | 3.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.6 | 3.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.6 | 10.0 | GO:0006415 | translational termination(GO:0006415) |
0.6 | 2.3 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.6 | 6.4 | GO:0070836 | caveola assembly(GO:0070836) |
0.6 | 5.8 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.6 | 2.3 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.6 | 1.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.6 | 2.3 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.6 | 0.6 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.6 | 1.7 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.6 | 1.7 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.6 | 1.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.6 | 16.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.6 | 17.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.6 | 1.1 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.6 | 2.8 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.6 | 0.6 | GO:0048069 | eye pigmentation(GO:0048069) |
0.6 | 1.1 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.6 | 7.7 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.6 | 2.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.6 | 21.0 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.5 | 4.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.5 | 6.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.5 | 5.5 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.5 | 1.1 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.5 | 1.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.5 | 1.1 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.5 | 1.6 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.5 | 3.1 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.5 | 1.5 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.5 | 16.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.5 | 2.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.5 | 2.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 1.5 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.5 | 3.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.5 | 4.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 2.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.5 | 9.0 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.5 | 3.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.5 | 1.5 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.5 | 2.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.5 | 5.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.5 | 1.9 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.5 | 8.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.5 | 6.2 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.5 | 1.9 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.5 | 0.5 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.5 | 3.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.5 | 4.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.5 | 4.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.5 | 1.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.5 | 1.8 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.5 | 1.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 1.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.5 | 25.7 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.4 | 1.3 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.4 | 2.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.4 | 6.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 5.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 1.8 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.4 | 10.6 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.4 | 4.4 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.4 | 0.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.4 | 0.9 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.4 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 11.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.4 | 0.9 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.4 | 2.5 | GO:0018377 | N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
0.4 | 2.5 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.4 | 40.4 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.4 | 3.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.4 | 0.8 | GO:0032202 | telomere assembly(GO:0032202) |
0.4 | 6.9 | GO:0061371 | determination of heart left/right asymmetry(GO:0061371) |
0.4 | 2.8 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.4 | 23.9 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.4 | 3.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.4 | 1.6 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.4 | 0.8 | GO:0035883 | enteroendocrine cell differentiation(GO:0035883) |
0.4 | 8.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.4 | 8.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.4 | 0.4 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.4 | 8.0 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.4 | 2.0 | GO:0043314 | negative regulation of cellular extravasation(GO:0002692) negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.4 | 1.2 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.4 | 46.5 | GO:0007059 | chromosome segregation(GO:0007059) |
0.4 | 7.9 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.4 | 0.4 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 1.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.4 | 0.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 0.8 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 0.7 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.4 | 0.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.4 | 6.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 3.7 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.4 | 4.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.4 | 2.6 | GO:0014029 | neural crest formation(GO:0014029) |
0.4 | 1.1 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.4 | 4.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.4 | 1.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.4 | 5.0 | GO:0042407 | cristae formation(GO:0042407) |
0.4 | 4.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 4.9 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.3 | 4.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 1.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 2.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.3 | 5.1 | GO:0051298 | centrosome duplication(GO:0051298) |
0.3 | 0.7 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.3 | 3.4 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.3 | 3.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 1.0 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.3 | 3.4 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.3 | 0.7 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.3 | 2.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.3 | 2.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.3 | 0.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 5.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 1.6 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 2.5 | GO:0048665 | neuron fate specification(GO:0048665) |
0.3 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 39.9 | GO:0006457 | protein folding(GO:0006457) |
0.3 | 2.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.3 | 3.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.3 | 0.6 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.3 | 0.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.3 | 0.3 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.3 | 12.9 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.3 | 2.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 1.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 2.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 2.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 0.8 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.3 | 1.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.3 | 7.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 1.7 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 2.8 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 5.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 2.4 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.3 | 1.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.3 | 1.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.3 | 2.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 2.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.3 | 1.8 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 0.8 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 2.3 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.3 | 2.3 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.2 | 0.7 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 2.5 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 1.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.7 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.2 | 1.0 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 4.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 3.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.2 | 3.5 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.2 | 2.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.2 | 8.7 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.2 | 2.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.9 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 1.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 4.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 2.0 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.2 | 3.1 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 3.9 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 3.7 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 1.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.6 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 3.0 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.2 | 3.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 1.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.8 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.2 | 0.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.2 | 0.4 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
0.2 | 6.5 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.2 | 8.1 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.2 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 3.0 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
0.2 | 0.4 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 1.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 3.2 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.2 | 4.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 2.5 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.2 | 0.2 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.2 | 1.6 | GO:0001736 | establishment of planar polarity(GO:0001736) establishment of tissue polarity(GO:0007164) |
0.2 | 1.1 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.2 | 8.4 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.2 | 0.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 1.2 | GO:0001841 | neural tube formation(GO:0001841) |
0.2 | 1.0 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.2 | 0.5 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.2 | 6.2 | GO:0006805 | xenobiotic metabolic process(GO:0006805) cellular response to xenobiotic stimulus(GO:0071466) |
0.2 | 0.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 6.7 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 0.8 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 0.3 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.2 | 1.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 1.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.3 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.2 | 5.8 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 8.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 1.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 1.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 9.8 | GO:0001843 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.2 | 1.9 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
0.2 | 3.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 3.2 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.2 | 1.4 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.2 | 0.5 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.2 | 1.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 4.9 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.2 | 1.7 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.2 | 0.8 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.1 | 0.6 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 1.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.3 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 4.6 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 1.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 5.1 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 2.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 1.7 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 3.0 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 2.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.6 | GO:0060948 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 9.7 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 38.7 | GO:0051301 | cell division(GO:0051301) |
0.1 | 1.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 1.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.1 | GO:0006404 | RNA import into nucleus(GO:0006404) |
0.1 | 1.3 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.1 | 5.4 | GO:0042307 | positive regulation of protein import into nucleus(GO:0042307) |
0.1 | 1.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 3.7 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.1 | 1.2 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 2.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 1.8 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 4.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.9 | GO:0060348 | bone development(GO:0060348) |
0.1 | 1.3 | GO:0071353 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
0.1 | 1.2 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.1 | 2.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.2 | GO:0051030 | snRNA transport(GO:0051030) |
0.1 | 2.2 | GO:0060425 | lung morphogenesis(GO:0060425) |
0.1 | 2.8 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.5 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.1 | 1.6 | GO:0031050 | dsRNA fragmentation(GO:0031050) production of miRNAs involved in gene silencing by miRNA(GO:0035196) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.1 | 0.2 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.1 | 1.6 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.8 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 1.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 1.9 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.4 | GO:1903286 | regulation of potassium ion import(GO:1903286) |
0.1 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:2000399 | negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 0.4 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 1.5 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 4.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 1.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.2 | GO:0042264 | peptidyl-aspartic acid modification(GO:0018197) regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.8 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.3 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 1.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 2.4 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 2.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.3 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.1 | 0.4 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.1 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 4.6 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.1 | 0.2 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.1 | 0.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 0.9 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.8 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.1 | 0.3 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.5 | GO:0009437 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.1 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.7 | GO:0023058 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.1 | 0.2 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.3 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.1 | 0.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 3.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.2 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.5 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 1.7 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.1 | GO:0021678 | third ventricle development(GO:0021678) |
0.1 | 14.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.2 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 0.6 | GO:0060563 | neuroepithelial cell differentiation(GO:0060563) |
0.0 | 0.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.0 | 0.5 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.0 | 0.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 1.0 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.5 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.4 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.4 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.0 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.7 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 0.1 | GO:0042271 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.1 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.0 | 0.8 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.7 | GO:0009168 | purine nucleoside monophosphate biosynthetic process(GO:0009127) purine ribonucleoside monophosphate biosynthetic process(GO:0009168) |
0.0 | 0.2 | GO:0003170 | heart valve development(GO:0003170) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.3 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.1 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.6 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
20.5 | 102.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
12.8 | 64.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
10.5 | 42.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
7.2 | 21.7 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
5.9 | 47.5 | GO:0005818 | aster(GO:0005818) |
5.9 | 29.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
5.6 | 22.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
5.5 | 22.2 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
5.3 | 15.9 | GO:0000799 | nuclear condensin complex(GO:0000799) |
5.3 | 15.9 | GO:0000801 | central element(GO:0000801) |
5.1 | 5.1 | GO:0042585 | germinal vesicle(GO:0042585) |
4.8 | 19.3 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
4.5 | 58.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
4.2 | 71.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
4.1 | 16.4 | GO:0035339 | SPOTS complex(GO:0035339) |
3.8 | 19.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
3.7 | 11.1 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
3.1 | 28.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
3.0 | 9.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
3.0 | 9.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
3.0 | 8.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
3.0 | 207.4 | GO:0000786 | nucleosome(GO:0000786) |
3.0 | 8.9 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
2.9 | 14.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.8 | 13.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
2.7 | 8.2 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
2.6 | 5.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
2.6 | 10.5 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
2.4 | 57.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
2.2 | 6.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
2.2 | 2.2 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
2.2 | 8.9 | GO:0032127 | dense core granule membrane(GO:0032127) |
2.2 | 8.9 | GO:0071942 | XPC complex(GO:0071942) |
2.1 | 32.0 | GO:0042555 | MCM complex(GO:0042555) |
2.1 | 8.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.9 | 7.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.9 | 100.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.8 | 27.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.8 | 25.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
1.8 | 5.4 | GO:1990423 | RZZ complex(GO:1990423) |
1.8 | 8.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.7 | 8.6 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.7 | 27.2 | GO:0045120 | pronucleus(GO:0045120) |
1.7 | 3.4 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
1.7 | 13.4 | GO:0042382 | paraspeckles(GO:0042382) |
1.7 | 16.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
1.7 | 16.6 | GO:0045298 | tubulin complex(GO:0045298) |
1.6 | 11.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.6 | 12.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.6 | 7.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.5 | 29.3 | GO:0010369 | chromocenter(GO:0010369) |
1.5 | 23.0 | GO:0031011 | Ino80 complex(GO:0031011) |
1.4 | 9.6 | GO:0072687 | meiotic spindle(GO:0072687) |
1.4 | 6.8 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
1.4 | 8.2 | GO:0034448 | EGO complex(GO:0034448) |
1.3 | 6.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.3 | 9.4 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
1.3 | 11.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.3 | 18.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
1.3 | 3.8 | GO:0035061 | interchromatin granule(GO:0035061) |
1.3 | 8.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
1.2 | 17.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.2 | 11.2 | GO:0034709 | methylosome(GO:0034709) |
1.2 | 15.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.2 | 13.2 | GO:0005688 | U6 snRNP(GO:0005688) |
1.2 | 4.7 | GO:0033269 | internode region of axon(GO:0033269) |
1.2 | 57.4 | GO:0005657 | replication fork(GO:0005657) |
1.2 | 1.2 | GO:1903349 | omegasome membrane(GO:1903349) |
1.2 | 4.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.2 | 23.0 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
1.1 | 10.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.1 | 8.7 | GO:0016580 | Sin3 complex(GO:0016580) |
1.1 | 7.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.1 | 1.1 | GO:0005687 | U4 snRNP(GO:0005687) |
1.1 | 121.3 | GO:0000776 | kinetochore(GO:0000776) |
1.1 | 5.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.0 | 8.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
1.0 | 35.0 | GO:0005876 | spindle microtubule(GO:0005876) |
1.0 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
1.0 | 11.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.9 | 7.6 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.9 | 16.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.9 | 5.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.9 | 3.7 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.9 | 21.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.9 | 11.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.9 | 39.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.9 | 7.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.8 | 64.1 | GO:0005814 | centriole(GO:0005814) |
0.8 | 3.3 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.8 | 3.2 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.8 | 1.6 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.8 | 54.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.8 | 15.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.8 | 0.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.8 | 8.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.8 | 4.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.8 | 3.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.7 | 7.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.7 | 8.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.7 | 2.9 | GO:0043293 | apoptosome(GO:0043293) |
0.7 | 2.8 | GO:0070187 | telosome(GO:0070187) |
0.7 | 2.1 | GO:0071914 | prominosome(GO:0071914) |
0.7 | 4.2 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.7 | 2.7 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.7 | 9.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.7 | 10.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.7 | 2.0 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.7 | 3.9 | GO:0097452 | GAIT complex(GO:0097452) |
0.6 | 5.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.6 | 4.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 16.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.6 | 68.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.6 | 6.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.6 | 1.8 | GO:0034657 | GID complex(GO:0034657) |
0.6 | 4.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.6 | 2.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 6.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 4.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.5 | 3.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.5 | 2.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.5 | 10.8 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.5 | 4.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.5 | 5.8 | GO:0016589 | NURF complex(GO:0016589) |
0.5 | 7.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.5 | 3.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.5 | 2.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 28.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.4 | 0.9 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.4 | 2.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 5.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.4 | 5.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.4 | 3.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 1.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 5.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.4 | 5.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.4 | 4.7 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 1.9 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.4 | 5.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.4 | 17.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 3.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.4 | 5.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 3.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 103.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.4 | 3.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 113.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.4 | 5.4 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.4 | 1.1 | GO:1990597 | TRAF2-GSTP1 complex(GO:0097057) AIP1-IRE1 complex(GO:1990597) |
0.4 | 23.1 | GO:0005844 | polysome(GO:0005844) |
0.3 | 1.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 3.4 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.3 | 2.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 10.8 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 1.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 0.6 | GO:0070531 | BRCA1-A complex(GO:0070531) BRISC complex(GO:0070552) |
0.3 | 3.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 0.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 1.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.3 | 1.9 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 3.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 5.6 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 2.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.6 | GO:0097443 | sorting endosome(GO:0097443) cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 0.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 1.8 | GO:0014704 | intercalated disc(GO:0014704) |
0.3 | 3.4 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 3.1 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 1.8 | GO:0071203 | F-actin capping protein complex(GO:0008290) WASH complex(GO:0071203) |
0.2 | 11.1 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 4.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 1.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 2.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 1.6 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 14.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 2.9 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 1.5 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 3.1 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.2 | 3.1 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 3.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 1.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.2 | 7.0 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 1.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.2 | 11.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.2 | 1.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 2.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 0.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 2.1 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 5.5 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 0.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 1.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 8.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 1.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 17.2 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.2 | 15.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 13.5 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 15.8 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.6 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 3.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.6 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 1.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 1.2 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 12.0 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 7.3 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 18.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 2.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.0 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 13.6 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.3 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.1 | 3.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 1.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.3 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 4.0 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 18.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 3.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 2.5 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.8 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 3.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 24.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 3.3 | GO:0016605 | PML body(GO:0016605) |
0.1 | 2.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.7 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 1.3 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 2.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 3.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 1.0 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 3.3 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 6.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.5 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.7 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 150.5 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 1.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.0 | 68.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
12.6 | 37.9 | GO:0035939 | microsatellite binding(GO:0035939) |
8.3 | 33.1 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
8.2 | 40.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
8.0 | 32.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
5.9 | 35.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
5.7 | 34.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
5.7 | 17.2 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
5.7 | 17.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
4.8 | 24.1 | GO:0043515 | kinetochore binding(GO:0043515) |
4.2 | 12.5 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
3.8 | 186.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
3.8 | 15.0 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
3.8 | 3.8 | GO:0015616 | DNA translocase activity(GO:0015616) |
3.7 | 3.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
3.6 | 14.4 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
3.4 | 27.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
3.3 | 10.0 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
3.3 | 36.3 | GO:0008430 | selenium binding(GO:0008430) |
3.2 | 3.2 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
3.1 | 33.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
3.1 | 27.5 | GO:0035173 | histone kinase activity(GO:0035173) |
3.0 | 9.0 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
3.0 | 8.9 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
2.6 | 34.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
2.6 | 28.7 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
2.5 | 17.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
2.5 | 35.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
2.3 | 7.0 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
2.2 | 8.9 | GO:0036435 | deubiquitinase activator activity(GO:0035800) K48-linked polyubiquitin binding(GO:0036435) |
2.2 | 8.6 | GO:0004096 | aminoacylase activity(GO:0004046) catalase activity(GO:0004096) |
2.1 | 10.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
2.1 | 12.4 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
2.0 | 10.1 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
2.0 | 8.1 | GO:0032357 | oxidized purine DNA binding(GO:0032357) |
2.0 | 13.8 | GO:0000150 | recombinase activity(GO:0000150) |
1.9 | 7.8 | GO:1990254 | keratin filament binding(GO:1990254) |
1.9 | 25.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.9 | 9.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.9 | 9.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.8 | 7.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.8 | 7.3 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
1.8 | 7.3 | GO:0008142 | oxysterol binding(GO:0008142) |
1.8 | 9.1 | GO:0042610 | CD8 receptor binding(GO:0042610) |
1.8 | 7.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
1.7 | 25.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
1.7 | 10.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.6 | 4.9 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.6 | 47.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.6 | 4.7 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
1.6 | 6.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
1.5 | 9.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.5 | 21.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.5 | 4.5 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.5 | 6.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.5 | 9.1 | GO:0045340 | mercury ion binding(GO:0045340) |
1.5 | 10.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.5 | 25.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.5 | 20.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
1.5 | 11.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.5 | 11.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.4 | 12.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
1.4 | 9.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.3 | 41.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.3 | 11.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.3 | 6.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
1.3 | 3.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.3 | 5.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.3 | 3.9 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
1.3 | 9.0 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
1.3 | 8.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.3 | 5.1 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
1.3 | 3.8 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
1.2 | 3.7 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) serine binding(GO:0070905) |
1.2 | 28.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.2 | 84.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
1.2 | 4.6 | GO:0047134 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) protein-disulfide reductase activity(GO:0047134) |
1.2 | 5.8 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
1.1 | 4.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
1.1 | 3.4 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
1.1 | 26.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.1 | 6.7 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
1.1 | 8.9 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
1.1 | 26.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.1 | 10.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
1.1 | 2.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
1.1 | 9.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.1 | 3.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
1.1 | 49.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
1.0 | 4.2 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
1.0 | 3.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
1.0 | 4.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.0 | 2.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.0 | 6.2 | GO:0042731 | PH domain binding(GO:0042731) |
1.0 | 20.5 | GO:0008483 | transaminase activity(GO:0008483) |
1.0 | 3.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.0 | 11.1 | GO:0035198 | miRNA binding(GO:0035198) |
1.0 | 3.9 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.0 | 10.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.0 | 3.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.0 | 5.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.0 | 3.8 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
1.0 | 4.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.9 | 4.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.9 | 5.6 | GO:0070728 | leucine binding(GO:0070728) |
0.9 | 3.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.9 | 8.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.9 | 8.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.9 | 2.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.9 | 4.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.9 | 6.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.9 | 7.0 | GO:0046790 | virion binding(GO:0046790) |
0.9 | 2.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.9 | 6.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.9 | 2.6 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.8 | 15.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.8 | 0.8 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.8 | 1.6 | GO:0005113 | patched binding(GO:0005113) |
0.8 | 3.3 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.8 | 3.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.8 | 8.9 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.8 | 2.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.8 | 18.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.8 | 15.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.8 | 9.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.8 | 0.8 | GO:0003681 | bent DNA binding(GO:0003681) |
0.8 | 7.5 | GO:0070990 | snRNP binding(GO:0070990) |
0.8 | 9.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 3.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.7 | 2.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.7 | 87.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.7 | 2.2 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.7 | 2.9 | GO:0016936 | galactoside binding(GO:0016936) |
0.7 | 3.5 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.7 | 4.2 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.7 | 4.2 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.7 | 3.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.7 | 8.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.7 | 2.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.7 | 3.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.7 | 6.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.7 | 4.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.7 | 5.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.7 | 2.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.7 | 9.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.7 | 2.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.7 | 7.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.6 | 12.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.6 | 1.3 | GO:0005119 | smoothened binding(GO:0005119) |
0.6 | 2.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.6 | 17.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.6 | 1.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.6 | 3.8 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.6 | 6.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.6 | 3.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 44.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.6 | 1.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.6 | 45.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.6 | 5.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.6 | 3.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.6 | 9.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 56.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.6 | 13.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.6 | 2.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.6 | 2.3 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.6 | 1.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.6 | 10.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.6 | 2.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.6 | 28.9 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.5 | 2.7 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.5 | 3.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.5 | 1.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.5 | 1.6 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.5 | 3.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 3.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 2.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.5 | 4.7 | GO:0035326 | enhancer binding(GO:0035326) |
0.5 | 5.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 6.7 | GO:0031386 | protein tag(GO:0031386) |
0.5 | 85.9 | GO:0001047 | core promoter binding(GO:0001047) |
0.5 | 1.5 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.5 | 5.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 2.0 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
0.5 | 1.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.5 | 14.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.5 | 16.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.5 | 2.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.5 | 2.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.5 | 3.3 | GO:0015288 | protein channel activity(GO:0015266) porin activity(GO:0015288) |
0.5 | 1.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.5 | 3.2 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.5 | 3.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.5 | 1.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.5 | 4.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.5 | 1.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.5 | 3.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 1.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 3.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.4 | 7.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.4 | 9.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 8.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 9.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.4 | 1.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.4 | 3.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.4 | 7.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 1.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 2.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 2.9 | GO:0043176 | amine binding(GO:0043176) |
0.4 | 15.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.4 | 7.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.4 | 2.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 2.0 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 2.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.4 | 2.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 0.4 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.4 | 2.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 1.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.4 | 4.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.4 | 0.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.4 | 3.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 4.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.4 | 1.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.4 | 2.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 74.6 | GO:0008017 | microtubule binding(GO:0008017) |
0.4 | 3.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.4 | 1.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.4 | 0.7 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.4 | 1.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.4 | 3.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 17.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 7.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.3 | 1.0 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.3 | 1.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 6.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 3.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 57.9 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 15.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.3 | 1.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 2.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.3 | 1.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 1.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.3 | 3.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 6.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 1.6 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 2.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 1.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.3 | 3.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 6.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 15.1 | GO:0005516 | calmodulin binding(GO:0005516) |
0.3 | 0.9 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.3 | 2.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 2.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 1.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.3 | 1.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 16.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.3 | 2.4 | GO:0016597 | amino acid binding(GO:0016597) |
0.3 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.3 | 1.3 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.3 | 1.0 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.2 | 1.0 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
0.2 | 1.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 4.4 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 1.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.7 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 5.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 0.9 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.7 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 12.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 2.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 2.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 10.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 3.6 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 7.9 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.2 | 5.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 1.1 | GO:0070404 | NADH binding(GO:0070404) |
0.2 | 13.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 3.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 3.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 3.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 18.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 33.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 2.8 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 1.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.6 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 0.4 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.2 | 6.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 4.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 5.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.6 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.2 | 0.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 1.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 4.5 | GO:0019902 | phosphatase binding(GO:0019902) |
0.2 | 11.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 4.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 2.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 16.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.2 | 0.9 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.8 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 10.4 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.2 | 12.8 | GO:0005506 | iron ion binding(GO:0005506) |
0.2 | 0.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 1.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.5 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 2.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 49.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 2.8 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.2 | 1.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 5.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 6.7 | GO:0008528 | G-protein coupled peptide receptor activity(GO:0008528) |
0.2 | 2.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 3.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.5 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.2 | 1.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 6.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 2.8 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 1.0 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 1.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 1.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.4 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.1 | 1.0 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 4.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 3.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 35.5 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.1 | 10.0 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 2.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.4 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.6 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 0.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.3 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.1 | 0.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 1.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 1.8 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.4 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.1 | 3.6 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 1.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.6 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.1 | 2.1 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.4 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 0.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 1.0 | GO:0008227 | G-protein coupled amine receptor activity(GO:0008227) |
0.1 | 20.1 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 0.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 1.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 10.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 1.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 2.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 2.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.8 | GO:0052744 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 0.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 1.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 1.6 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.7 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 10.9 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.9 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.6 | GO:0016859 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
0.0 | 0.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.3 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.0 | 1.1 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.8 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.0 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.2 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.4 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.5 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.4 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 0.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 338.9 | PID_PLK1_PATHWAY | PLK1 signaling events |
3.7 | 136.8 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
3.6 | 50.6 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
2.0 | 96.3 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
1.9 | 69.5 | PID_AURORA_B_PATHWAY | Aurora B signaling |
1.7 | 49.9 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.5 | 44.0 | PID_AURORA_A_PATHWAY | Aurora A signaling |
1.3 | 24.1 | PID_MYC_PATHWAY | C-MYC pathway |
1.3 | 8.8 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
1.0 | 27.8 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
1.0 | 58.5 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
0.9 | 10.1 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
0.8 | 29.3 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
0.8 | 54.9 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
0.8 | 9.5 | PID_BARD1_PATHWAY | BARD1 signaling events |
0.8 | 27.4 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.7 | 22.5 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
0.7 | 14.1 | PID_ATR_PATHWAY | ATR signaling pathway |
0.6 | 17.9 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 7.1 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
0.6 | 7.2 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
0.5 | 42.1 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
0.5 | 24.5 | PID_E2F_PATHWAY | E2F transcription factor network |
0.5 | 4.1 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 28.6 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 12.2 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.5 | 1.8 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 11.5 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.4 | 29.6 | PID_BETA_CATENIN_NUC_PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.4 | 7.9 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
0.4 | 11.0 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 2.1 | PID_IL6_7_PATHWAY | IL6-mediated signaling events |
0.3 | 20.9 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 8.7 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
0.3 | 10.3 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 15.6 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 4.0 | PID_IL23_PATHWAY | IL23-mediated signaling events |
0.3 | 9.5 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 8.5 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 7.4 | PID_RAS_PATHWAY | Regulation of Ras family activation |
0.2 | 2.9 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 5.8 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
0.2 | 2.6 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
0.2 | 15.4 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
0.2 | 2.5 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
0.2 | 0.8 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 1.8 | PID_FOXO_PATHWAY | FoxO family signaling |
0.2 | 9.2 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 2.1 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 7.1 | PID_CDC42_PATHWAY | CDC42 signaling events |
0.2 | 5.6 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 9.1 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
0.1 | 0.7 | PID_CXCR4_PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.0 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
0.1 | 3.6 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.0 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
0.1 | 4.9 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 4.7 | PID_BMP_PATHWAY | BMP receptor signaling |
0.1 | 3.1 | PID_FGF_PATHWAY | FGF signaling pathway |
0.1 | 2.1 | PID_CD8_TCR_PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 6.3 | ST_INTEGRIN_SIGNALING_PATHWAY | Integrin Signaling Pathway |
0.1 | 2.3 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.3 | PID_CD40_PATHWAY | CD40/CD40L signaling |
0.1 | 1.3 | PID_RHOA_PATHWAY | RhoA signaling pathway |
0.1 | 5.4 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
0.1 | 0.6 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 2.3 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.6 | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.1 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.7 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
0.1 | 2.4 | PID_REG_GR_PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.4 | PID_NFAT_3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 2.7 | PID_P53_REGULATION_PATHWAY | p53 pathway |
0.1 | 0.8 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.3 | PID_THROMBIN_PAR1_PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.8 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.6 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 1.0 | PID_TRKR_PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.3 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 1.2 | PID_AVB3_INTEGRIN_PATHWAY | Integrins in angiogenesis |
0.0 | 0.3 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 12.7 | REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
6.1 | 103.9 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
5.1 | 81.1 | REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
4.7 | 9.4 | REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
4.2 | 218.0 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
3.8 | 34.3 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
3.7 | 59.1 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
3.7 | 87.8 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
3.5 | 94.5 | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Activation of the pre-replicative complex |
3.3 | 83.3 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
3.3 | 72.4 | REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
2.8 | 75.6 | REACTOME_KINESINS | Genes involved in Kinesins |
2.1 | 177.3 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
2.1 | 25.6 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
1.9 | 26.8 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.9 | 13.1 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
1.7 | 14.9 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.5 | 9.1 | REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.4 | 25.8 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.4 | 40.7 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
1.3 | 13.4 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
1.2 | 12.2 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.2 | 87.7 | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
1.2 | 15.5 | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
1.2 | 14.1 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
1.1 | 28.7 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.1 | 11.9 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
1.1 | 23.6 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
1.0 | 14.2 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.0 | 81.8 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
0.9 | 0.9 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.9 | 2.6 | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.9 | 2.6 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
0.8 | 43.8 | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.8 | 10.1 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.8 | 13.9 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.8 | 7.7 | REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.7 | 2.2 | REACTOME_G_PROTEIN_ACTIVATION | Genes involved in G-protein activation |
0.7 | 14.8 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
0.7 | 47.9 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.7 | 4.2 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.7 | 8.0 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
0.7 | 86.4 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
0.7 | 26.3 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.7 | 11.7 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
0.6 | 3.2 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
0.6 | 9.0 | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.6 | 9.8 | REACTOME_PURINE_SALVAGE | Genes involved in Purine salvage |
0.6 | 8.2 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.6 | 2.8 | REACTOME_PACKAGING_OF_TELOMERE_ENDS | Genes involved in Packaging Of Telomere Ends |
0.6 | 9.5 | REACTOME_EXTENSION_OF_TELOMERES | Genes involved in Extension of Telomeres |
0.5 | 9.1 | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.5 | 2.1 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 6.9 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.5 | 7.4 | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.5 | 5.1 | REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.5 | 1.4 | REACTOME_PD1_SIGNALING | Genes involved in PD-1 signaling |
0.5 | 5.1 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
0.4 | 8.0 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 20.3 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
0.4 | 8.8 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 1.7 | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 11.7 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 3.7 | REACTOME_MRNA_CAPPING | Genes involved in mRNA Capping |
0.4 | 5.3 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 2.4 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.4 | 11.6 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 11.6 | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.4 | 5.3 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 4.5 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.4 | 40.1 | REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 1.7 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 7.8 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 2.2 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 2.1 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 4.4 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 11.3 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 3.1 | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 20.5 | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 0.8 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 2.4 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 5.2 | REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.3 | 15.4 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 7.0 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
0.2 | 11.7 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 2.0 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
0.2 | 0.4 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 5.7 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 1.7 | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 1.6 | REACTOME_SIGNALLING_TO_RAS | Genes involved in Signalling to RAS |
0.2 | 1.6 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 6.4 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 3.3 | REACTOME_MUSCLE_CONTRACTION | Genes involved in Muscle contraction |
0.2 | 7.8 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 3.9 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 4.0 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 7.1 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 1.0 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.8 | REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 10.9 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 12.0 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 8.7 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
0.1 | 2.7 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 4.1 | REACTOME_GLUCOSE_METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.7 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 8.4 | REACTOME_METABOLISM_OF_CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.1 | 1.1 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 2.0 | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.8 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 3.4 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.0 | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.8 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.1 | REACTOME_DOWNSTREAM_TCR_SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 2.7 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.9 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.9 | REACTOME_METABOLISM_OF_NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.1 | 1.7 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 4.5 | REACTOME_TRANSLATION | Genes involved in Translation |
0.1 | 1.1 | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.6 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 3.9 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.5 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.4 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.5 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 1.3 | REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.4 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.2 | REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.3 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.6 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.2 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.4 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.0 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.6 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.6 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |